Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes

Maturitas

Volumn 43, Issue 3, 2002, Pages 157-164

  Manwaring, Paul ^a   Phoon, Stephen ^a   Diamond, Terence ^a   Howes, Laurence Guy ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Angiotensin II; Blood pressure; Estrogen; Noradrenaline; Progestogens; Stress; Type 2 diabetes

Indexed keywords

ANGIOTENSIN; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE; NORADRENALIN; PLACEBO; RENIN;

ARITHMETIC; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HORMONE SUBSTITUTION; HUMAN; ISOMETRIC EXERCISE; MENTAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; STRESS; TIME;

ADMINISTRATION, ORAL; ANGIOTENSIN II; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE; MIDDLE AGED; NOREPINEPHRINE; POSTMENOPAUSE; STRESS; TREATMENT OUTCOME;

EQUIDAE;

EID: 0037145935     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00029-4     Document Type: Article

References (17)

1. Muller J.E., Tofler G.H., Edelman E. Probable trigger factors of onset of acute myocardial infarction. Clin. Cardiol. 12:1989;472.
2. Owens J.F., Stoney C.M., Matthews K.A. Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation. 88:1993;2794.
3. Rich-Edwards J.W., Manson J.E., Hennekans C.H., Burning J.E. The primary prevention of coronary heart disease in women. New Engl. J. Med. 332:1995;1758.
4. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann. Intern. Med. 115:1991;455.
5. Kannel W.B. Lipids diabetes and coronary heart disease: insights from the Framingham study. Am. Heart J. 110:1985;1100.
6. Christalieb A.R., Janka H., Kraus B., Gleason R.E., et al. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes. 1976:25;268.
7. Pollare P., Lithell H., Morin C., Hvarmer A., Ljunghall S. Metabolic effects of diltiazem and atenolol. Results from a randomized, double blind study with parallel groups. J. Hypertens. 7:1989;551-559.
8. Austin C.E. Chronic and acute effects of oestrogens on vascular contractility. J. Hypertens. 18:2000;1365-1378.
9. Mercuro G., Zoncu S., Piano D., Pilia I., Lao A., Melis G.B., Cherchi A. Estradiol-17 beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am. J. Hypertens. 11:(8 Pt. 1):1998;909-913.
10. Von Eiff AW, Pierkasrski C. Stress reactions of normotensives and hypertensives and the influence of female sex hormones on blood pressure. Prog Brain Res 1977:289-99.
11. Minami J., Kawano Y., Makino Y., Matsuoka H., Takishita S. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function ambulatory blood pressure and heart rate in patients with essential hypertension. Br. J. Clin. Pharmacol. 50:2000;615-620.
12. Spence J.D., Munoz C., Huff M.W., Tokmakjian S. Effect of amlodipine on hemodynamic and endocrine responses to mental stress. Am. J. Hypertens. 13:(5 Pt. 1):2000;518-522.
13. Muneta S., Kohara K., Hiwada K. Effects of benidipine hydrochloride on 24-h blood pressure and blood pressure responses to mental stress. Int. J. Clin. Pharmacol. Ther. 37:1999;141-147.
14. Drury P.L., Smith G.M., Ferriss J.B. Increased vasopressor responsiveness to angiotensin II in type I (insulin-dependent) diabetic patients without complications. Diabetologia. 27:1984;174.
15. Sudhir K., Esler M., Jennings G.L., Komesaroff P.A. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in premenopausal women. Hypertension. 30:1997;1538.
16. Schunkert H., Danser J., Hense H., Derkx F.H.M., Kurzinger S., Riegger G.A.J. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation. 95:1997;39.
17. Proundler A.J., Ahmed A.I., Crook D., Fogelman I., Rymer J.M., Stevenson J.C. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet. 346:1995;89.